PETMED EXPRESS INC Profit Breakdown
Profit breakdown shows how much each product earned: one column per product, one row per year or quarter. All amounts are the filed figures for that period.
- PETMED EXPRESS INC revenue for the quarter ending 2024-03-31 was $66.5M, a 6.56% increase year-over-year.
- PETMED EXPRESS INC revenue for the quarter ending 2023-12-31 was $65.32M, a 10.95% increase year-over-year.
- PETMED EXPRESS INC revenue for the quarter ending 2023-09-30 was $71M, a 8.79% increase year-over-year.
- PETMED EXPRESS INC revenue for the quarter ending 2023-06-30 was $78.24M, a 11.71% increase year-over-year.
- PETMED EXPRESS INC revenue for fiscal 2024 was $281.06M, a 9.54% increase from fiscal 2023.
- PETMED EXPRESS INC revenue for fiscal 2023 was $256.58M, a 5.77% decline from fiscal 2022.
- PETMED EXPRESS INC revenue for fiscal 2022 was $272.28M, a 10.31% decline from fiscal 2021.
- PETMED EXPRESS INC revenue for fiscal 2021 was $303.58M, a 6.85% increase from fiscal 2020.
- Available history
- 2010-03-31 to 2026-06-30
- Data captured
Profit by product
Gross margin: each quarter (3 month)
| Quarter end | Reportable |
|---|---|
| 2026-06-30 | $11.33M derived |
| 2025-06-30 | $14.40M derived |
Net Income (Loss) Attributable to Parent: each quarter (3 month)
| Quarter end | Reportable |
|---|---|
| 2026-06-30 | -$6.14M |
| 2025-06-30 | -$34.15M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVS HEALTH Corp (CVS) | United States | $108.783B | 27.06 |